Peripheral/Endo

SANUWAVE Receives U.S. and European Patents for Intracorporeal Shockwave Systems for Treating Blood Vessels in Cardiology and Endovascular Fields

SUWANEE, GA, April 02, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, received United States Patent US 10,238,405 on March 26, 2019 entitled “Blood Vessel Treatment […]

First US Patient Treated with Cook Medical’s Recently Approved Zenith® Dissection Endovascular System

BLOOMINGTON, Ind.–(BUSINESS WIRE)–Following the recent FDA approval of Cook Medical’s Zenith Dissection Endovascular System, Cooper University Health Care in Camden, New Jersey, has treated the first patient in the US with the device as part of Cook’s US commercial launch. “We are committed to helping patients by developing a variety […]

Healogics® Brings Vein Ablation Services to Wound Care Centers®

JACKSONVILLE, Fla., March 21, 2019 /PRNewswire/ — Healogics, the nation’s largest provider of advanced chronic wound care services, today announced they have added vein ablation to their in-house service offerings through a new program called Healogics® VeinCare. This program allows Healogics to provide patients with a higher level of care in a more […]

BD Statement on Paclitaxel-Coated Devices

FRANKLIN LAKES, N.J., March 21, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement related to the recent letter from FDA to health care providers regarding paclitaxel-coated devices: On March 15, the FDA issued a letter to health care providers regarding paclitaxel-coated devices […]

Endonovo Therapeutics Partners with SunMED Medical Systems

LOS ANGELES, CA, March 20, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), Alan Collier, Endonovo’s Chief Executive Officer, stated “We are pleased to announce our partnership with SunMED Medical Solutions (“SunMED”). SunMED is one of the premier medical equipment distributors and claims experts in the country.  […]

Rex Medical Completes Patient Enrollment for the REVEAL Peripheral Atherectomy U.S. Trial

March 19, 2019 10:14 AM Eastern Daylight Time CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Rex Medical, L.P., a medical device design and development company, today announced the successful completion of enrollment in the Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization (REVEAL) IDE clinical trial. The REVEAL trial is a single arm, […]

Data from the Non-interventional EMIT-AF/VTE Study Shows Low Thromboembolic and Bleeding Event Rates in Unselected Elderly AF/VTE Patients on Oral, Once-daily LIXIANA®▼ Undergoing Diagnostic or Therapeutic Procedures

MUNICH, March 19, 2019 /PRNewswire/ — In 2019, the Edoxaban Clinical Research Programme will deliver new evidence on LIXIANA®▼ (edoxaban) use in clinical practice. EMIT-AF/VTE is one of the first sets of data to be presented EMIT-AF/VTE is a large observational, multicentre, multinational study on edoxaban peri-procedural management and outcomes It is […]

ReCor Medical Announces 6 Month On-Medication Results from RADIANCE-HTN SOLO Clinical Trial and the First Randomization in the RADIANCE-II Pivotal Study

PALO ALTO, Calif., March 17, 2019 /PRNewswire/ — ReCor Medical, Inc. (“ReCor”) announced the 6 month “on-medication” results from its RADIANCE-HTN SOLO clinical trial with simultaneous publication in Circulation, and the first randomization of patients in its RADIANCE-II pivotal trial of its Paradise® Renal Denervation System for the treatment of uncontrolled hypertension. Today at […]

Endospan Secures CE Mark Approval for Branched Endovascular Repair of the Aortic Arch with Its NEXUS™ Aortic Arch Repair System

March 19, 2019 08:30 AM Eastern Daylight Time HERZLIA, Israel–(BUSINESS WIRE)–Endospan, a pioneer in off-the-shelf, minimally invasive endovascular repair of Aortic Arch Disease comprising both aneurysms and dissections, today announced that it has received CE-marking for its NEXUS™ Stent Graft System. Diseases of the aortic arch present surgeons with challenging […]

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

FRANKLIN LAKES, N.J., March 14, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow […]